Young Blind Child Melatonin Treatment Study

Stopped early · Not applicable

Conditions studied: Blindness

In brief

The primary goal of this study is to identify the presence of desynchronized circadian rhythms in 25 children by measuring melatonin secretion in serial blood or saliva samples, and to rule out any primary sleep disorders.

Key facts

Study ID

NCT00688935

Run by

Oregon Health and Science University

People needed

9

Starts

2005-01-01

Expected to finish

2015-05-01

Last updated by the study team

2019-11-27

Who can join

Age: 1 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 1-20 years
• Blindness for the past year (verified by an ophthalmologic exam), but otherwise in general good health.

You may not qualify if…

• Abnormal heart, lung, kidney, liver disease or a primary sleep disorder,
• Significant clinical abnormalities (other than blindness),
• Use of medications with known effects on melatonin metabolism (e.g. beta-adrenergic blocking drugs or tricyclic antidepressants).

Where it is running

• Sleep and Mood Disorders Lab, Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.